📣 VC round data is live. Check it out!

Almoosa Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for Almoosa Health and similar public comparables like Med Life, Ardent Health, Mitra Keluarga, Ramsay Santé and more.

Almoosa Health Overview

About Almoosa Health

Almoosa Health Co provides integrated healthcare services that include primary, acute and rehabilitative care along with ancillary services such as pharmaceuticals, home healthcare and telemedicine. The company is also designing, constructing and developing hospitals care centers. The reported segments are: Medical Services and Hospital: Focused on delivering medical care and treatment; Rehabilitation Centre: Specializing in rehabilitation-related services; Pharmacy: Engaged in the sale of medicines.


Founded

1994

HQ

Saudi Arabia

Employees

N/A

Financials (LTM)

Revenue: $404M
EBITDA: ($93M)

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Almoosa Health Financials

Almoosa Health reported last 12-month revenue of $404M and negative EBITDA of ($93M).

In the same LTM period, Almoosa Health generated $132M in gross profit, ($93M) in EBITDA losses, and $63M in net income.

Revenue (LTM)


Almoosa Health P&L

In the most recent fiscal year, Almoosa Health reported revenue of $384M and EBITDA of $98M.

Almoosa Health is profitable as of last fiscal year, with gross margin of 32%, EBITDA margin of 25%, and net margin of 17%.

See analyst estimates for Almoosa Health
LTMLast FY20242025202620272028
Revenue$404M$384M$326M$384M
Gross Profit$132M$122M$101M$122M
Gross Margin33%32%31%32%
EBITDA($93M)$98M$61M$98M
EBITDA Margin(23%)25%19%25%
EBIT Margin17%17%14%14%
Net Profit$63M$64M$13M$64M
Net Margin16%17%4%17%
Net Debt—$186M——

Financial data powered by Morningstar, Inc.

Almoosa Health Stock Performance

Almoosa Health has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


Almoosa Health's stock price is $31.07.

Almoosa Health share price decreased by 13.2% in the last 30 days, and by 25.3% in the last year.

Almoosa Health has an EPS (earnings per share) of $1.45.

See more trading valuation data for Almoosa Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B-1.1%-13.2%-21.1%-25.3%$1.45

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Almoosa Health Valuation Multiples

Almoosa Health trades at 4.0x EV/Revenue multiple, and (17.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for Almoosa Health

EV / Revenue (LTM)


Almoosa Health Financial Valuation Multiples

As of May 20, 2026, Almoosa Health has market cap of $1B and EV of $2B.

Almoosa Health has a P/E ratio of 22.0x.

LTMLast FY20242025202620272028
EV/Revenue4.0x4.2x5.0x4.2x
EV/EBITDA(17.5x)16.5x26.4x16.5x
EV/EBIT23.8x25.3x35.1x29.2x
EV/Gross Profit12.3x13.3x16.1x13.3x
P/E22.0x21.5x102.9x21.5x
EV/FCF—(17.1x)(74.7x)(17.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Almoosa Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Almoosa Health Margins & Growth Rates

Almoosa Health grew revenue by 16% but EBITDA decreased by 207% in the last fiscal year.

In the most recent fiscal year, Almoosa Health reported gross margin of 32%, EBITDA margin of 25%, and net margin of 17%.

See estimated margins and future growth rates for Almoosa Health

Almoosa Health Margins

Last FY202420252026202720282029
Gross Margin32%31%32%34%
EBITDA Margin25%19%25%(24%)
EBIT Margin17%14%14%17%
Net Margin17%4%17%15%
FCF Margin(25%)(7%)(25%)—

Almoosa Health Growth Rates

FY+1/FY24/2525/2626/2727/2828/29
Revenue Growth16%18%16%
Gross Profit Growth24%21%24%
EBITDA Growth(207%)59%(207%)
EBIT Growth16%20%34%
Net Profit Growth5%379%5%
FCF Growth—338%—

Data powered by FactSet, Inc. and Morningstar, Inc.

Almoosa Health Operational KPIs

Almoosa Health's Rule of 40 is (8%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Almoosa Health's Rule of X is 16% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Almoosa Health
LTMLast FY20242025202620272028
Rule of 40(2%)(8%)——
Bessemer Rule of X29%16%——
S&M Expenses to Revenue2%2%2%2%
G&A Expenses to Revenue14%15%2%2%
Opex to Revenue—17%17%17%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Almoosa Health Competitors

Almoosa Health competitors include Med Life, Ardent Health, Mitra Keluarga, Ramsay Santé, Aevis Victoria, Agilon Health, Burjeel Holdings, Dr Agarwals, Spire Healthcare Group and Pennant Group.

Most Almoosa Health public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Med Life2.9x2.4x20.6x16.3x
Ardent Health0.5x0.5x5.7x5.8x
Mitra Keluarga3.7x3.6x9.8x9.5x
Ramsay Santé0.9x—8.3x—
Aevis Victoria1.7x1.9x24.3x23.9x
Agilon Health0.2x0.2x(4.3x)(7.2x)
Burjeel Holdings1.5x1.5x7.6x7.7x
Dr Agarwals7.8x7.1x29.4x26.2x

This data is available for Pro users. Sign up to see all Almoosa Health competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Almoosa Health

When was Almoosa Health founded?Almoosa Health was founded in 1994.
Where is Almoosa Health headquartered?Almoosa Health is headquartered in Saudi Arabia.
Who is the CEO of Almoosa Health?Almoosa Health's CEO is Malek Abdulaziz Abdullah Almoosa.
Is Almoosa Health publicly listed?Yes, Almoosa Health is a public company listed on Tadawul.
What is the stock symbol of Almoosa Health?Almoosa Health trades under 4018 ticker.
When did Almoosa Health go public?Almoosa Health went public in 2025.
Who are competitors of Almoosa Health?Almoosa Health main competitors include Med Life, Ardent Health, Mitra Keluarga, Ramsay Santé, Aevis Victoria, Agilon Health, Burjeel Holdings, Dr Agarwals, Spire Healthcare Group, Pennant Group.
What is the current market cap of Almoosa Health?Almoosa Health's current market cap is $1B.
What is the current revenue of Almoosa Health?Almoosa Health's last 12 months revenue is $404M.
What is the current revenue growth of Almoosa Health?Almoosa Health revenue growth (NTM/LTM) is 21%.
What is the current EV/Revenue multiple of Almoosa Health?Current revenue multiple of Almoosa Health is 4.0x.
Is Almoosa Health profitable?No, Almoosa Health is not profitable.
What is the current EBITDA of Almoosa Health?Almoosa Health has negative EBITDA and is not profitable.
What is Almoosa Health's EBITDA margin?Almoosa Health's last 12 months EBITDA margin is (23%).
What is the current EV/EBITDA multiple of Almoosa Health?Current EBITDA multiple of Almoosa Health is (17.5x).
How many companies Almoosa Health has acquired to date?Almoosa Health hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Almoosa Health has invested to date?Almoosa Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Almoosa Health

Lists including Almoosa Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial